Modern medicine has saved millions of lives over the years, and improved countless more. To ensure drugs’ safety, companies spend millions developing, testing, and getting their drugs approved by the federal Food and Drug Administration (FDA). However, some drugs are found, years after they’ve entered the market, that they can cause harm.
Patients who’ve been harmed by defective drugs might face extra medical bills, lost wages, and further injury. If that harm was caused by the drug’s manufacturer, they could be eligible for financial compensation by becoming part of a mass tort lawsuit. At any one time, dozens of mass torts are being litigated. As of 2022, the following drugs and manufacturers are being litigated for causing harm to users:
- Elmiron, used for treating interstitial cystitis (IC), has been linked to an increased risk of eye disease and vision loss
- Jardiance, which helps type-2 diabetics manage their blood sugar, can increase the risk of developing Fournier’s Gangrene when taken with certain other drugs
- Zantac, a popular heartburn medication, has been linked to an increased risk for developing cancer
- Xeljanz, used to treat rheumatoid arthritis and ulcerative colitis, has been linked to major cardiovascular events and various cancers
- Prilosec, Nexium, and other proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) have been linked to an increased likelihood of strokes, bone fractures, acute kidney injury, renal failure, and heart damage
- and others
If you or a loved one has developed cancer or another long-term illness after taking one or more of these drugs, call the defective drug lawyers at Gordon McKernan Injury Attorneys for a free legal consultation.
GET HELP NOW!